Alliance Growers Diversifies into Jamaica
2018年2月27日 - 11:23PM
InvestorsHub NewsWire
Vancouver, British Columbia -- February 27, 2018 -- InvestorsHub
NewsWire -- Alliance Growers Corp. (CSE: ACG) (FSE:
1LA) (WKN: A2DFYX) ("Alliance Growers" or
the "Company") is pleased to announce that it has
entered advanced negotiations for a significant strategic
investment with a private licensed Jamaican cannabis company.
The private Jamaican company has established operations with
production facilities with a Tier 2 Cultivator's license (cultivate
land with ganja for medical, scientific and therapeutic purposes)
and a Tier 2 Processing license (process ganja for medical,
scientific and medical purposes, including the manufacturing of
ganja-based products). The company's mission is to produce quality
medicinal products in Jamaica that have the unique qualities of
Jamaica's holistic healing culture. The Jamaican company will be
exporting cannabinoids and terpenoids through joint ventures with
selective Canadian and European Licensed Distributers, and develop
and brand world class cannabis flower, extracts, infused products
for the growing international cannabis industry.
Alliance Growers expansion into Jamaica will be a strong strategic
move for the following reasons:
- Provides further geographical diversification
- Anticipated lower cost setting than Canada
- Canopy Growth Corp. has a subsidiary in Jamaica which validates
the potential of the country by one of the largest, most respected
Cannabis companies in the world.
- Canada-based Timeless Herbal Care Limited announced it has
secured a US$100-million deal to develop medical marijuana products
in Jamaica for the international market.
- Export potential to Canada, Europe and Uruguay and other South
American countries.
- With a population of approximately 2.8 million, there is also
the potential for the local market due to high acceptance of usage
among the population.
Commenting on the negotiations to diversify into the Jamaican
cannabis industry, Dennis Petke, Alliance Growers' President and
CEO, noted "The opportunity to build our shareholder's equity by
joining forces with thriving licensed Jamaican licensed cannabis
company where industry giants such as Canopy Growth are already
established is a tremendous opportunity for growth. Diversifying
Alliance Growers into Jamaica, a country with a high level of
acceptance of cannabis, will broaden Alliance Grower's global
diversification and complement the Company's strategy of building a
global cannabis company that is going to be where the market is
will be going not where the market is today."
About Alliance Grower's
Alliance Growers Corp is a diversified cannabis company driven by
the Company's 'Four Pillars' Organization Plan — Cannabis Botany
Centre, Strategic ACMPR Investments, CBD Oil Supply and
Distribution, and Research and Development.
Alliance Growers has finalized its a new business partnership with
WFS Pharmagreen Inc., to jointly develop and operate a
40,000-square foot facility to be the first of its kind in Western
Canada to house a DNA Botany lab, extraction facility and Tissue
Culture Plantlet Production facility to service the Cannabis market
and agriculture market in general. The proposed Cannabis Botany
Centre will grow Cannabis plantlets using proprietary tissue
culture propagation, specifically the "Chibafreen Invitro Plant
Production System", which assures consistent composition and purity
of each plantlet for the growers.
Alliance Growers has entered into an exclusive agreement to acquire
a late stage licensed producer applicant, Biocannatech, to become a
licensed producer under Health Canada's access to cannabis for
medical purposes regulations ("ACMPR") in Quebec. Alliance Growers
will supply financing and resources to build out the medical
marijuana facility in preparation for the inspection required to
obtain a growing license. Once Health Canada is satisfied with a
successful crop, Alliance Growers will be granted its distribution
license.
This acquisition allows the Company an opportunity to become a
licensed producer in the Province of Quebec and gain an in-road to
provide tissue culture plantlets to all licensed producers in
Quebec.
Further, Alliance Growers has been negotiating to obtain other
exclusive Canadian distribution agreements for certain proprietary
products for support of the Cannabis growing industry in addition
to possible partnerships with Licensed Producer Applicants at
various stages in the Health Canada License process.
For further information, please visit the Company's website at
www.alliancegrowers.com or the Company's profile
at www.sedar.com.
If you would like to be added to Alliance Growers' news
distribution list, please send your email address
to newsletter@alliancegrowers.com
On behalf of the board of directors of
ALLIANCE GROWERS CORP.
"Dennis Petke"
Dennis Petke
President and CEO
For more information contact:
Dennis Petke
Tel: 778-331-4266
DennisPetke@alliancegrowers.com
Rob Grace
Communications Consultant
Tel: 778-998-5431
RobDGrace@gmail.com
THE CANADIAN SECURITIES EXCHANGE HAS NOT REVIEWED AND DOES NOT
ACCEPT RESPONSIBILITY FOR THE ACCURACY OR ADEQUACY OF THIS
RELEASE.
FORWARD LOOKING INFORMATION
This news release contains forward-looking statements and
forward-looking information within the meaning of applicable
securities laws. These statements relate to future events or future
performance. All statements other than statements of historical
fact may be forward-looking statements or information. More
particularly and without limitation, the news release contains
forward-looking statements and information relating to Company's
corporate strategy. The forward-looking statements and information
are based on certain key expectations and assumptions made by
management of the Company, including, without limitation, the
Company's ability to carry out its business plan. Although
management of the Company believes that the expectations and
assumptions on which such forward-looking statements and
information are based are reasonable, undue reliance should not be
placed on the forward-looking statements and information since no
assurance can be given that they will prove to be correct.
Forward-looking statements and information are provided for the
purpose of providing information about the current expectations and
plans of management of the Company relating to the future. Readers
are cautioned that reliance on such statements and information may
not be appropriate for other purposes, such as making investment
decisions. Since forward-looking statements and information address
future events and conditions, by their very nature they involve
risks and uncertainties. Actual results could differ materially
from those currently anticipated due to a number of factors and
risks. These include, but are not limited to, the Company's ability
to identify and complete additional suitable acquisitions to
further the Company's growth as well as risks associated with the
medical marijuana industry in general, such as operational risks in
development and production delays or changes in plans with respect
to development projects or capital expenditures; the uncertainty of
the capital markets; the uncertainty of receiving the required
licenses, production, costs and expenses; health, safety and
environmental risks; marketing and transportation; loss of markets;
environmental risks; competition; incorrect assessment of the value
of the potential market; ability to access sufficient capital from
internal and external sources; failure to obtain required
regulatory and other approvals and changes in legislation,
including but not limited to tax laws and regulated regulations.
Accordingly, readers should not place undue reliance on the
forward-looking statements, timelines and information contained in
this news release. Readers are cautioned that the foregoing list of
factors is not exhaustive.
The forward-looking statements and information contained in this
news release are made as of the date hereof and no undertaking is
given to update publicly or revise any forward-looking statements
or information, whether as a result of new information, future
events or otherwise, unless so required by applicable securities
laws or the Canadian Securities Exchange. The forward-looking
statements or information contained in this news release are
expressly qualified by this cautionary statement.
Alliance Growers (CSE:ACG)
過去 株価チャート
から 10 2024 まで 10 2024
Alliance Growers (CSE:ACG)
過去 株価チャート
から 10 2023 まで 10 2024